BioFirst Overview

  • Founded
  • 2008
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 360
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $14.2M
Latest Deal Amount

BioFirst General Information

Description

Developer of plant proteases products intended to substitute chemicals products. The company produces and markets natural technologies and products in agriculture, para pharmaceuticals, agri-foodstuffs, cosmetics, and health care and are environmentally friendly and sustainable alternatives to existing chemical products, enabling customers to get products that are safe for them as well as the environment.

Contact Information

Website
www.biofirst.be
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Other Chemicals and Gases
Other Industries
Other Commercial Products
Industrial Chemicals
Primary Office
  • Drève Richelle 161 B4
  • 1410 Waterloo
  • Belgium
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BioFirst Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 22-Nov-2011 $14.2M 000.00 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view BioFirst’s complete valuation and funding history, request access »

BioFirst Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioFirst Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Compagnie du Bois Sauvage Corporation Minority 000 0000 000000 0
Florinvest Corporate Venture Capital Minority 000 0000 000000 0
To view BioFirst’s complete investors history, request access »